FDA
-
-
-
-
-
-
-
Boston Scientific announces results for fourth quarter and full year 2025
-
-
-
-
-
-
-
Penumbra (PEN) PT Raised to $225 at Piper Sandler
-
-
-
-
-
-
-
Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients
-
-
-
-
-
-
-
Saxena White P.A. Files Securities Fraud Class Action Against Penumbra, Inc.
-
-
-
-
-
-
-
After-Hours Stock Movers 02/27: (PHH) (AAXN) (ETSY) Higher; (BGS) (TSRO) (CELG) Lower (more...)
-
-
327,753 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

